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Abstract






Validated models exist to describe the blood glucose (BG) metabolism's variability for ICU patients [1-3]. Model-based tight glycemic control (TGC) protocols can maintain the normoglycemic state in ICU patients. Avoiding the severe variability of blood glucose, as  well hypoglycemia and hyperglycemia, which can be a projecting factor for mortality [1, 6]. STAR (Stochastic TARget) is a validated [14, 23] TGC  protocol, based on model ICING (Intensive Control Insulin-Nutrition- Glucose). The method is already set to clinical application on ICU in Christchurch, (New Zealand), Liege (Belgium) [7], Gyula (Hungary) [8, 9]  for MICU (medical intensive care unit) , CICU (cardiac intensive care unit) and specific patient cohort as well [10]. Our aim is the extension of the method for other specific patient-cohort; liver transplantation (LT). However the benefits of the normoglycemic state for these patients is not yet completely proven [11, 12]. 
 Budapest Transplantation Clinic (BTC) provided measurement data from 23 patients, undergoing orthotopic liver transplantation (oLT); the blood glucose concentration, surgery events and times, feeding and insulin therapy. The most of the Patients were suffered in alcoholic cirrhosis.
 The criteria of the effective STAR control is an appropriate model, which can describe the metabolic changes over time. This paper describes a model based retrospective analyzes, to define those BG behaviors, where the modifications on ICING, aiming the hepatic transplant application are necessary. During Liver transplantation the metabolic system faces alternations in blood glucose dynamic, which don't occurs on  “standard” ICU, preliminary studies report about the loss of endogenous glucose input or the too high rate non-insulin mediated glucose removal  or both [13-15]. 
This article is addressed for analyzing and quantizing those phenomena, which occur generally during the LT and the model is not built up to deal with their dynamics. Knowing the trends of deviations in BG and in time allow us to make adjustments on the metabolic model to follow the real metabolic process. 
2	Methods 
2.1	Data & Surgery
23 LT-Patients' data were obtained from the Budapest Transplantation Clinic. Surgery events, blood glucose concentration and administered exogenous insulin and nutrition were recorded. 


Image 1. describes the trend of the Blood glucose concentration in the certain surgery phases A (pre-anhepatic phase), B (anhepatic phase), C (reperfusion between the unclamping of portal vein and hepatic artery), D (post-anhepatic phase I. [13, 15] ) and E (post-anhepatic phase II.)

The nutrition was provided in parenteral way, the goal feed was 4 [g/hr] according to the hospital protocol, the insulin were administered in infusion. 
The oLT can divided into several phases (Image 1.); the pre-anhepatic (pre-AH) phase (dissection of the porta hepatic), the anhepatic (AH) phase (clamping of the blood supplies) and the post-anhepatic phase (post-AH) winch begins with the reperfusion through unclamping the porta vein the hepatic artery and vena cava.
The anhepatic (AH) states  lasted 80±25 [min], the time between the portal vein's and hepatic artery's unclamping was 54±29 [min] the administered nutrition 0.3281±0.2418 [mmol/l] for the whole surgery, 0.3083±0.2136 [mmol/l] 0.2112±0.1962 [mmol/l] for the AH states and the timespan between the unclamping the portal vein and hepatic artery. Except the parenteral nutrition the patients didn't received any feeding. 
2.2	Model
The ICING model (Equation (1)-(4)) describes a three- compartment system which contains the insulin changes  in the blood  in the interstitium and the glucose changes [1]. The Blood Glucose changes arises from the glucose releases as well the uptakes in terms of physiological constants like endogenous glucose production (EGP), non-insulin mediated glucose uptake by the central nervous system (CNS), and other organs (Pg). The exogenous input is due to the parenteral nutrition (Pn) in our case. The glucose uptake by the cells  is evaluated retrospectively,  by integration method with taking in account the interstitial insulin- and blood glucose concentration. The glucose uptake of the cells is also characterized by the insulin sensitivity SI, which indicates the ability  of the body for the present insulin's utilization rate. The method for  SI value's estimation was validated with independent clinical data [16, 17].






(In equation (1) only the parenteral feeding was considered, due to the BTC' feeding-regime.)
2.3	Model based assessment of the clinical data 
The proper values for the physiological parameter-changes are not available, however their (EGP, Pg) direct measurement  would be beneficial. The measurement- methods are highly restricted [18-20] due to the surgical and physiological conditions.  The SI variability conveys information about the metabolic processes, as well as the alternations of  physiological parameters [21].
  The SI value is limited because of trivial physiological considerations; it can't drop above  1e-7 [-].






The non-physiological range of the SI value (SI<0) let us know the deviations' features, through the SI related term's integration over the related timespan (Equation 5).    

Image 3.  The  histogram shows the extraordinary BG dynamics' frequency in time, during the following surgery phases; the pre-anhepatic phase until the hepatectomy,  the anhepatic phase from the hepatectomy until the portal vein reperfusion, and the post-anhepatic phase from portal vein reperfusion. 
3	Results
The fitting ability of the model for the LT  use was analyzed on Image 2.   by indicating the times, where the BG dynamics deviate from the MICU (medical intensive care unit) or CICU (cardiac intensive care unit). Each line represents a patient along the vertical axis, the horizontal axis shows the time. The patients data were shifted to  t=0 portal vein reperfusion. Almost every patient episode shows an extraordinary BG glucose dynamics. By integrating the SI related term (equation 5), we obtained also quantitative differences between LT patients and validated ICU patient model. A threshold value was set to distinguish the dynamics more nuanced. The threshold value  2 mmol/l BG input above the validated ICU patients (Image 2. A) shows the importance of the portal vein reperfusion. It points on 11 patients, with higher extra BG input above  the threshold value 2 mmol/l (Image 2. A), as 5 patients can be accounted to the pre-anhepatic phase and 6 ones to the post-anhepatic phase with similar behavior. In some cases due to the not appropriate interpolation between blood glucose samples the  the integration intervals overlap two phases (anhepatic and portal vein unclamping at patients 1125, 1139, 1146, 1151). 




In the pre-anhepatic phase the general deviations are caused by stress response for surgery interventions. 
 The reperfusion by the release of portal vein clamp causes general a rapids rise of BG causing a severe hyper- glycemia, the phenomenon is well known among clinicians [22, 23]. Based on the data also in the post anhepatic phase, a critical time interval can be defined  accounts to  500 minutes after portal vein unclamping. 
For accurate models and model-based glycemic control  in hepatic-transplant we need to find accurate pG and EGP because it is from these  results clearly not the same as general MICU and CICU patients. Where metabolism is extraordinary compared to a validated ICU patient model, EGP or PG or both  very different. 
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